Nanologica AB Statistics

Total Valuation

Nanologica AB has a market cap or net worth of SEK 97.19 million. The enterprise value is 118.99 million.

Market Cap	97.19M
Enterprise Value	118.99M

Important Dates

The next estimated earnings date is Thursday, July 10, 2025.

Earnings Date	Jul 10, 2025
Ex-Dividend Date	n/a

Share Statistics

Nanologica AB has 88.36 million shares outstanding. The number of shares has increased by 73.15% in one year.

Current Share Class	88.36M
Shares Outstanding	88.36M
Shares Change (YoY)	+73.15%
Shares Change (QoQ)	+20.00%
Owned by Insiders (%)	10.95%
Owned by Institutions (%)	17.76%
Float	32.80M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.80
PB Ratio	1.52
P/TBV Ratio	1.52
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.02
EV / Sales	5.88
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.30

Financial Position

The company has a current ratio of 5.43, with a Debt / Equity ratio of 0.78.

Current Ratio	5.43
Quick Ratio	2.04
Debt / Equity	0.78
Debt / EBITDA	n/a
Debt / FCF	-0.55
Interest Coverage	-8.84

Financial Efficiency

Return on equity (ROE) is -157.83% and return on invested capital (ROIC) is -34.83%.

Return on Equity (ROE)	-157.83%
Return on Assets (ROA)	-28.06%
Return on Invested Capital (ROIC)	-34.83%
Return on Capital Employed (ROCE)	-48.96%
Revenue Per Employee	1.27M
Profits Per Employee	-3.69M
Employee Count	16
Asset Turnover	0.17
Inventory Turnover	1.00

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -81.10% in the last 52 weeks. The beta is 0.44, so Nanologica AB's price volatility has been lower than the market average.

Beta (5Y)	0.44
52-Week Price Change	-81.10%
50-Day Moving Average	1.19
200-Day Moving Average	2.05
Relative Strength Index (RSI)	44.12
Average Volume (20 Days)	321,183

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Nanologica AB had revenue of SEK 20.25 million and -59.03 million in losses. Loss per share was -0.94.

Revenue	20.25M
Gross Profit	3.50M
Operating Income	-52.31M
Pretax Income	-59.03M
Net Income	-59.03M
EBITDA	-51.21M
EBIT	-52.31M
Loss Per Share	-0.94

Full Income Statement

Balance Sheet

The company has 28.35 million in cash and 50.14 million in debt, giving a net cash position of -21.80 million or -0.25 per share.

Cash & Cash Equivalents	28.35M
Total Debt	50.14M
Net Cash	-21.80M
Net Cash Per Share	-0.25
Equity (Book Value)	63.94M
Book Value Per Share	0.72
Working Capital	80.85M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -91.18 million and capital expenditures -8,000, giving a free cash flow of -91.19 million.

Operating Cash Flow	-91.18M
Capital Expenditures	-8,000
Free Cash Flow	-91.19M
FCF Per Share	-1.03

Full Cash Flow Statement

Margins

Gross margin is 17.28%, with operating and profit margins of -258.30% and -291.48%.

Gross Margin	17.28%
Operating Margin	-258.30%
Pretax Margin	-291.48%
Profit Margin	-291.48%
EBITDA Margin	-252.85%
EBIT Margin	-258.30%
FCF Margin	n/a

Dividends & Yields

Nanologica AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-73.15%
Shareholder Yield	n/a
Earnings Yield	-60.74%
FCF Yield	-93.82%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Nanologica AB has an Altman Z-Score of -2.86. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.86
Piotroski F-Score	n/a